IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Pfizer Selects Prosonix Technology

11:46 AM MDT | October 3, 2008 | Deepti Ramesh

Ultrasonic process technology company Prosonix (Oxford, U.K.) says its Prosonitron reactor and sonocrystallization process technology has been selected by Pfizer for the pharma group’s active pharmaceutical ingredients (API) manufacturing facilities in Ireland. The Prosonitron technology was selected after an extended period of collaboration and testing with Pfizer’s R&D team at Sandwich, U.K., Prosonix says. The Prosonitron technology will be used in the controlled crystallization and production of a number of Pfizer products, Prosonix says. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa